How does Reye's syndrome differ from salicylate toxicity?

Reye's Syndrome vs. Salicylate Toxicity: Key Differences

Reye's syndrome and salicylate toxicity are distinct clinical entities with fundamentally different pathophysiology, despite salicylates being a potential trigger for Reye's syndrome in susceptible children. The critical distinction lies in their underlying mechanisms, histopathology, and clinical contexts.

Pathophysiology

Reye's syndrome is a mitochondrial disorder characterized by acute hepatic dysfunction and encephalopathy, typically triggered in children recovering from viral infections (particularly influenza or varicella) who have been exposed to salicylates 1, 2. The syndrome involves:

• Mitochondrial injury with characteristic ultrastructural changes: All hepatocyte mitochondria become enlarged, pleomorphic, with expanded matrix and absent mitochondrial dense bodies 3
• Primary metabolic derangement affecting fatty acid oxidation
• Hyperammonemia as a leading factor in brain damage 4

Salicylate toxicity is a direct poisoning from excessive salicylate exposure with entirely different mechanisms:

• Direct uncoupling of oxidative phosphorylation
• Disruption of cellular metabolism through multiple pathways
• Acid-base disturbances (mixed respiratory alkalosis and metabolic acidosis)
• CNS toxicity from salicylate accumulation 5

Histopathologic Differences

The liver pathology definitively distinguishes these conditions 3:

Reye's Syndrome:

• Swollen hepatocytes with microvesicular fat and central nuclei distributed diffusely
• Depleted or absent glycogen on PAS staining (5 of 6 cases showed complete absence)
• Diminished succinic acid dehydrogenase activity
• All mitochondria uniformly affected with characteristic ultrastructural abnormalities
• Minimal to no inflammation or necrosis 3, 6

Salicylate Intoxication:

• Nearly normal liver by light microscopy
• Minimal lipid accumulation
• Normal glycogen content and succinic acid dehydrogenase activity
• Normal-appearing mitochondria and peroxisomes on electron microscopy 3

Clinical Context and Presentation

Reye's Syndrome:

• Occurs in children/teenagers recovering from viral illness (chicken pox, flu-like symptoms) 1, 2
• Biphasic presentation: initial viral illness followed by sudden deterioration with vomiting and altered mental status
• Hyperammonemia (mean 172.4±71.3 μmol/L in one series) 4
• Hypoglycemia common (mean 35.2±17.0 mg/dL) 4
• Cerebral edema prominent (9 of 12 cases) 6
• High mortality (41.7% in one series) 4

Salicylate Toxicity:

• Direct relationship to salicylate ingestion/exposure
• Altered consciousness in 62% 5
• Vomiting in 22%, hyperthermia in 43% 5
• Characteristic acid-base disturbance with respiratory alkalosis initially
• Pulmonary edema in 5% 5
• Mortality 11% in extracorporeal treatment series 5

Critical Diagnostic Distinction

When diagnosis is unclear, liver biopsy with electron microscopy is necessary for definitive diagnosis 3. This is particularly important because:

• Salicylate exposure can occur in both conditions
• Some children with Reye's syndrome have been treated with salicylates 3
• The histopathology and ultrastructural findings are distinctly different despite potential salicylate exposure in both

The Salicylate-Reye's Connection

While salicylates can trigger Reye's syndrome in susceptible children, salicylate intoxication itself does not produce the characteristic mitochondrial and hepatic pathology of Reye's syndrome 3. The mechanism by which salicylates trigger Reye's syndrome involves:

• Potentiation of calcium-induced mitochondrial membrane damage 7
• Induction of mitochondrial permeability transition in susceptible individuals 4
• This occurs only in specific contexts (viral infection, possible underlying metabolic disorders) 8

Common Pitfall: Assuming that elevated salicylate levels in a child with encephalopathy automatically indicates salicylate toxicity rather than Reye's syndrome. The presence of therapeutic or even toxic salicylate levels does not exclude Reye's syndrome—the distinction requires assessment of the clinical context (recent viral illness), metabolic derangements (hyperammonemia, hypoglycemia), and ideally liver histopathology if diagnosis is uncertain 3, 6.